Cancer

 

Melanoma Risk for Patients Treated With Biologics Is Inconclusive

May 21, 2020

Researchers writing in JAMA Dermatology this week report that patients with inflammatory bowel disease, rheumatoid arthritis, and psoriasis who are treated with biologics may have a "clinically meaningful" increase in melanoma risk, but the jury is still out.

Study Confirms Skin Cancer Risk with Methotrexate

February 20, 2020

A double-blind, placebo-controlled, randomized clinical trial has confirmed that low-dose methotrexate is associated with an increased risk of skin cancer, according to a study published this week in the Annals of Internal Medicine.